{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T13:07:22Z","timestamp":1789132042068,"version":"build-2803163510"},"reference-count":175,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.beem.2026.102083","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T16:28:58Z","timestamp":1769790538000},"page":"102083","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Surgery for prolactinoma"],"prefix":"10.1016","volume":"40","author":[{"given":"Mendel","family":"Castle-Kirszbaum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"McCormack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.beem.2026.102083_bib1","article-title":"The epidemiology, diagnosis and treatment of Prolactinomas: the old and the new","volume":"33","author":"Chanson","year":"2019","journal-title":"Best Pr Res Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.beem.2026.102083_bib2","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/s41574-023-00886-5","article-title":"Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement","volume":"19","author":"Petersenn","year":"2023","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"10.1016\/j.beem.2026.102083_bib3","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s11102-024-01392-1","article-title":"Quality of life in Prolactinoma: a systematic review","volume":"27","author":"Castle-Kirszbaum","year":"2024","journal-title":"Pituitary"},{"issue":"14","key":"10.1016\/j.beem.2026.102083_bib4","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1056\/NEJM199410063311403","article-title":"A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea","volume":"331","author":"Webster","year":"1994","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.beem.2026.102083_bib5","doi-asserted-by":"crossref","first-page":"5256","DOI":"10.1210\/jcem.86.11.8054","article-title":"Resistance to cabergoline as compared with bromocriptine in hyperprolactinemia: prevalence, clinical definition, and therapeutic strategy","volume":"86","author":"Di Sarno","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.beem.2026.102083_bib6","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s11102-014-0617-2","article-title":"Current drug withdrawal strategy in prolactinoma patients treated with cabergoline: a systematic review and meta-analysis","volume":"18","author":"Hu","year":"2015","journal-title":"Pituitary"},{"issue":"1","key":"10.1016\/j.beem.2026.102083_bib7","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1530\/EO-21-0038","article-title":"Dopamine agonist therapy for prolactinomas: do we need to rethink the place of surgery in prolactinoma management?","volume":"2","author":"De Sousa","year":"2022","journal-title":"Endocr Oncol"},{"issue":"5","key":"10.1016\/j.beem.2026.102083_bib8","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s11102-023-01346-z","article-title":"Care trajectories of surgically treated patients with a prolactinoma: why did they opt for surgery?","volume":"26","author":"van Trigt","year":"2023","journal-title":"Pituitary"},{"issue":"2","key":"10.1016\/j.beem.2026.102083_bib9","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1210\/jc.2010-1692","article-title":"Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline","volume":"96","author":"Melmed","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.beem.2026.102083_bib10","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1365-2265.2006.02562.x","article-title":"Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas","volume":"65","author":"Casanueva","year":"2006","journal-title":"Clin Endocrinol"},{"issue":"7","key":"10.1016\/j.beem.2026.102083_bib11","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1210\/jcem.84.7.5810","article-title":"Cabergoline in the treatment of hyperprolactinemia: a study in 455 patients","volume":"84","author":"Verhelst","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.beem.2026.102083_bib12","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgz144","article-title":"Surgery as a viable alternative first-line treatment for prolactinoma patients. a systematic review and meta-analysis","volume":"105","author":"Zamanipoor Najafabadi","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.beem.2026.102083_bib13","doi-asserted-by":"crossref","first-page":"3709","DOI":"10.1210\/jc.2016-2008","article-title":"Dopamine agonists can reduce cystic prolactinomas","volume":"101","author":"Faje","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.beem.2026.102083_bib14","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s12020-021-02953-1","article-title":"Speed of response to dopaminergic agents in prolactinomas","volume":"75","author":"Hage","year":"2022","journal-title":"Endocrine"},{"issue":"3","key":"10.1016\/j.beem.2026.102083_bib15","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s11102-024-01384-1","article-title":"Prolactin-secreting tumors, dopamine agonists and pregnancy: a longitudinal experience of a tertiary neuroendocrine center","volume":"27","author":"Prencipe","year":"2024","journal-title":"Pituitary"},{"issue":"11","key":"10.1016\/j.beem.2026.102083_bib16","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.4158\/EP15804.OR","article-title":"Short-term decline in prolactin concentrations can predict future prolactin normalization, tumor shrinkage, and time to remission in men with macroprolactinomas","volume":"21","author":"Tirosh","year":"2015","journal-title":"Endocr Pract"},{"key":"10.1016\/j.beem.2026.102083_bib17","first-page":"dgaf540","article-title":"How to define success in prolactinoma treatment\u2014a systematic review and theoretical framework","author":"van Trigt","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.beem.2026.102083_bib18","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1365-2265.1993.tb02372.x","article-title":"The efficacy and tolerability of long-term cabergoline therapy in hyperprolactinaemic disorders: an open, uncontrolled, multicentre study. European Multicentre Cabergoline Study Group","volume":"39","author":"Webster","year":"1993","journal-title":"Clin Endocrinol"},{"issue":"12","key":"10.1016\/j.beem.2026.102083_bib19","doi-asserted-by":"crossref","first-page":"4721","DOI":"10.1210\/jc.2007-2758","article-title":"Prospective study of high-dose cabergoline treatment of prolactinomas in 150 patients","volume":"93","author":"Ono","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.beem.2026.102083_bib20","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1530\/EJE-12-0236","article-title":"Prolactinomas resistant to standard doses of cabergoline: a multicenter study of 92 patients","volume":"167","author":"Vroonen","year":"2012","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"10.1016\/j.beem.2026.102083_bib21","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/j.1365-2265.1992.tb01485.x","article-title":"Dose-dependent suppression of serum prolactin by cabergoline in hyperprolactinaemia: a placebo controlled, double blind, multicentre study","volume":"37","author":"Webster","year":"1992","journal-title":"Clin Endocrinol"},{"issue":"4","key":"10.1016\/j.beem.2026.102083_bib22","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1046\/j.1365-2265.1997.1300952.x","article-title":"Treatment of macroprolactinoma with cabergoline: a study of 85 patients","volume":"46","author":"Ferrari","year":"1997","journal-title":"Clin Endocrinol"},{"issue":"5","key":"10.1016\/j.beem.2026.102083_bib23","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1210\/er.2005-9998","article-title":"Advances in the treatment of prolactinomas","volume":"27","author":"Gillam","year":"2006","journal-title":"Endocr Rev"},{"issue":"6","key":"10.1016\/j.beem.2026.102083_bib24","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/cen.15120","article-title":"Visual morbidity in macroprolactinoma: a retrospective cohort study","volume":"101","author":"Rudman","year":"2024","journal-title":"Clin Endocrinol"},{"issue":"6","key":"10.1016\/j.beem.2026.102083_bib25","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1210\/edrv.22.6.0451","article-title":"Dopamine as a Prolactin (PRL) Inhibitor","volume":"22","author":"Ben-Jonathan","year":"2001","journal-title":"Endocr Rev"},{"key":"10.1016\/j.beem.2026.102083_bib26","doi-asserted-by":"crossref","first-page":"768","DOI":"10.3389\/fendo.2018.00768","article-title":"The mechanism and pathways of dopamine and dopamine agonists in prolactinomas","volume":"9","author":"Liu","year":"2019","journal-title":"Front Endocrinol"},{"issue":"3","key":"10.1016\/j.beem.2026.102083_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0018097","article-title":"Dopamine-induced apoptosis of lactotropes is mediated by the short isoform of D2 receptor","volume":"6","author":"Radl","year":"2011","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.beem.2026.102083_bib28","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1159\/000156116","article-title":"Genes differentially expressed in prolactinomas responsive and resistant to dopamine agonists","volume":"89","author":"Passos","year":"2008","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.beem.2026.102083_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.791633","article-title":"Resistance to dopamine agonists in pituitary tumors: molecular mechanisms","volume":"12","author":"Pivonello","year":"2022","journal-title":"Front Endocrinol"},{"issue":"2","key":"10.1016\/j.beem.2026.102083_bib30","first-page":"199","article-title":"Ki-67 and clinical correlations in patients with resistant prolactinomas","volume":"50","author":"Lu","year":"2020","journal-title":"Ann Clin Lab Sci"},{"issue":"1","key":"10.1016\/j.beem.2026.102083_bib31","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s12902-020-0543-4","article-title":"Predictors of dopamine agonist resistance in prolactinoma patients","volume":"20","author":"Vermeulen","year":"2020","journal-title":"BMC Endocr Disord"},{"issue":"3","key":"10.1016\/j.beem.2026.102083_bib32","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1210\/jc.2014-3670","article-title":"Macroprolactinomas in children and adolescents: factors associated with the response to treatment in 77 patients","volume":"100","author":"Salenave","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.beem.2026.102083_bib33","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3803\/EnM.2014.29.3.280","article-title":"Early prediction of long-term response to cabergoline in patients with macroprolactinomas","volume":"29","author":"Lee","year":"2014","journal-title":"Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.beem.2026.102083_bib34","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1530\/EJE-21-0561","article-title":"Shrinkage by the third month predicts long-term response of macroprolactinoma after cabergoline","volume":"185","author":"Biagetti","year":"2021","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"10.1016\/j.beem.2026.102083_bib35","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s11102-010-0290-z","article-title":"Cabergoline versus bromocriptine in the treatment of hyperprolactinemia: a systematic review of randomized controlled trials and meta-analysis","volume":"14","author":"dos Santos Nunes","year":"2011","journal-title":"Pituitary"},{"issue":"14","key":"10.1016\/j.beem.2026.102083_bib36","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1056\/NEJM199410063311403","article-title":"A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea","volume":"331","author":"Webster","year":"1994","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.beem.2026.102083_bib37","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1001\/jamainternmed.2014.5262","article-title":"Reports of pathological gambling, hypersexuality, and compulsive shopping associated with dopamine receptor agonist drugs","volume":"174","author":"Moore","year":"2014","journal-title":"JAMA Intern Med"},{"issue":"6452","key":"10.1016\/j.beem.2026.102083_bib38","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1136\/bmj.289.6452.1101","article-title":"Psychotic reactions during treatment of pituitary tumours with dopamine agonists","volume":"289","author":"Turner","year":"1984","journal-title":"Br Med J (Clin Res Ed"},{"issue":"2","key":"10.1016\/j.beem.2026.102083_bib39","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1007\/s12020-016-1088-1","article-title":"Dopa-testotoxicosis: disruptive hypersexuality in hypogonadal men with prolactinomas treated with dopamine agonists","volume":"55","author":"De Sousa","year":"2017","journal-title":"Endocrine"},{"issue":"3","key":"10.1016\/j.beem.2026.102083_bib40","doi-asserted-by":"crossref","first-page":"dgz076","DOI":"10.1210\/clinem\/dgz076","article-title":"Impulse control disorders in dopamine agonist-treated hyperprolactinemia: prevalence and risk factors","volume":"105","author":"De Sousa","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.beem.2026.102083_bib41","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1210\/jc.2018-02202","article-title":"Dopamine agonist-induced impulse control disorders in patients with prolactinoma: a cross-sectional multicenter study","volume":"104","author":"Dogansen","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.beem.2026.102083_bib42","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1056\/NEJMoa054830","article-title":"Valvular heart disease and the use of dopamine agonists for Parkinson\u2019s disease","volume":"356","author":"Zanettini","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.beem.2026.102083_bib43","article-title":"A meta-analysis of the prevalence of cardiac valvulopathy in hyperprolactinemic patients treated with Cabergoline","author":"Stiles","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.beem.2026.102083_bib44","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/cen.13940","article-title":"Echocardiography and monitoring patients receiving dopamine agonist therapy for hyperprolactinaemia: a joint position statement of the British Society of Echocardiography, the British Heart Valve Society and the Society for Endocrinology","volume":"90","author":"Steeds","year":"2019","journal-title":"Clin Endocrinol"},{"issue":"6","key":"10.1016\/j.beem.2026.102083_bib45","doi-asserted-by":"crossref","first-page":"e1833","DOI":"10.1210\/clinem\/dgae652","article-title":"The changing treatment paradigm for prolactinoma\u2014a prospective series of 100 consecutive neurosurgical cases","volume":"110","author":"van Trigt","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.beem.2026.102083_bib46","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1530\/EJE-11-1000","article-title":"Outcomes of transsphenoidal surgery in prolactinomas: improvement of hormonal control in dopamine agonist-resistant patients","volume":"166","author":"Primeau","year":"2012","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"10.1016\/j.beem.2026.102083_bib47","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.3171\/2025.1.JNS241645","article-title":"Examining the viability of modern endoscopic endonasal surgery as a first-line treatment for macroprolactinomas: a multicentric study on the results and significance of the highest preoperative prolactin level in predicting long-term surgical outcomes","volume":"143","author":"Khaleghi","year":"2025","journal-title":"J Neurosurg"},{"issue":"10","key":"10.1016\/j.beem.2026.102083_bib48","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/S2213-8587(25)00227-X","article-title":"Prolactin-secreting adenomas: pathogenesis, diagnosis, and management","volume":"13","author":"Fleseriu","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"10.1016\/j.beem.2026.102083_bib49","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1530\/EJE-17-0933","article-title":"Treatment of aggressive pituitary tumours and carcinomas: results of a European Society of Endocrinology (ESE) survey 2016","volume":"178","author":"McCormack","year":"2018","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"10.1016\/j.beem.2026.102083_bib50","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s00701-005-0498-2","article-title":"Clinical and histological correlations in prolactinomas, with special reference to bromocriptine resistance","volume":"147","author":"Delgrange","year":"2005","journal-title":"Acta Neurochir"},{"issue":"5","key":"10.1016\/j.beem.2026.102083_bib51","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1530\/EJE-09-0012","article-title":"Characterization of resistance to the prolactin-lowering effects of cabergoline in macroprolactinomas: a study in 122 patients","volume":"160","author":"Delgrange","year":"2009","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"10.1016\/j.beem.2026.102083_bib52","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/modpathol.2015.151","article-title":"Silent subtype 3 pituitary adenomas are not always silent and represent poorly differentiated monomorphous plurihormonal Pit-1 lineage adenomas","volume":"29","author":"Mete","year":"2016","journal-title":"Mod Pathol"},{"issue":"6","key":"10.1016\/j.beem.2026.102083_bib53","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1530\/EJE-14-0990","article-title":"Expression of estrogen receptor alpha is associated with prolactin pituitary tumor prognosis and supports the sex-related difference in tumor growth","volume":"172","author":"Delgrange","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.beem.2026.102083_bib54","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11102-019-00997-1","article-title":"Pathology of prolactinomas: any predictive value?","volume":"23","author":"Lopes","year":"2020","journal-title":"Pituitary"},{"issue":"1","key":"10.1016\/j.beem.2026.102083_bib55","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1159\/000499382","article-title":"Clinical, pathological, and molecular factors of aggressiveness in lactotroph tumours","volume":"109","author":"Trouillas","year":"2019","journal-title":"Neuroendocrinology"},{"issue":"1","key":"10.1016\/j.beem.2026.102083_bib56","doi-asserted-by":"crossref","DOI":"10.1111\/bpa.13302","article-title":"The 2022 WHO classification of tumors of the pituitary gland: an update on aggressive and metastatic pituitary neuroendocrine tumors","volume":"35","author":"Casar-Borota","year":"2025","journal-title":"Brain Pathol"},{"issue":"11","key":"10.1016\/j.beem.2026.102083_bib57","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/s41574-021-00550-w","article-title":"Aggressive pituitary tumours and pituitary carcinomas","volume":"17","author":"Raverot","year":"2021","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.beem.2026.102083_bib58","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1159\/000318494","article-title":"Gender differences in macroprolactinomas: study of clinical features, outcome of patients and ki-67 expression in tumor tissue","volume":"38","author":"Fainstein Day","year":"2010","journal-title":"Front Horm Res"},{"issue":"7","key":"10.1016\/j.beem.2026.102083_bib59","first-page":"2102","article-title":"Sex-related difference in the growth of prolactinomas: a clinical and proliferation marker study","volume":"82","author":"Delgrange","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.beem.2026.102083_bib60","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00401-024-02736-8","article-title":"Genome-wide loss of heterozygosity predicts aggressive, treatment-refractory behavior in pituitary neuroendocrine tumors","volume":"147","author":"Lin","year":"2024","journal-title":"Acta Neuropathol"},{"issue":"1","key":"10.1016\/j.beem.2026.102083_bib61","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1038\/s41467-020-16052-8","article-title":"Somatic SF3B1 hotspot mutation in prolactinomas","volume":"11","author":"Li","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.beem.2026.102083_bib62","unstructured":"Raverot G. Revised European Society of Endocrinology Clinical Practice Guideline for the management of aggressive pituitary tumours and pituitary carcinomas."},{"issue":"3","key":"10.1016\/j.beem.2026.102083_bib63","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s11102-008-0091-9","article-title":"Quality of life in women with microprolactinoma treated with dopamine agonists","volume":"11","author":"Cesar de Oliveira Naliato","year":"2008","journal-title":"Pituitary"},{"issue":"2","key":"10.1016\/j.beem.2026.102083_bib64","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1023\/B:PITU.0000004798.27230.ed","article-title":"Quality of life in patients with a pituitary adenoma","volume":"6","author":"Johnson","year":"2003","journal-title":"Pituitary"},{"key":"10.1016\/j.beem.2026.102083_bib65","doi-asserted-by":"crossref","DOI":"10.5402\/2012\/675310","article-title":"Long-term health-related quality of life of surgically treated pituitary adenoma patients: a descriptive study","volume":"2012","author":"Raappana","year":"2012","journal-title":"ISRN Endocrinol"},{"issue":"5","key":"10.1016\/j.beem.2026.102083_bib66","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/j.1365-2265.2008.03288.x","article-title":"Disease-specific impairments in quality of life during long-term follow-up of patients with different pituitary adenomas","volume":"69","author":"van der Klaauw","year":"2008","journal-title":"Clin Endocrinol"},{"issue":"2","key":"10.1016\/j.beem.2026.102083_bib67","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1530\/EJE-07-0259","article-title":"Quality of life is decreased in female patients treated for microprolactinoma","volume":"157","author":"Kars","year":"2007","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"10.1016\/j.beem.2026.102083_bib68","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/cen.13915","article-title":"Quality of life is significantly impaired in both secretory and non-functioning pituitary adenomas","volume":"90","author":"Vega-Beyhart","year":"2019","journal-title":"Clin Endocrinol"},{"issue":"1","key":"10.1016\/j.beem.2026.102083_bib69","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s11102-020-01089-1","article-title":"Healthcare utilization and costs among prolactinoma patients: a cross-sectional study and analysis of determinants","volume":"24","author":"van der Meulen","year":"2021","journal-title":"Pituitary"},{"issue":"1","key":"10.1016\/j.beem.2026.102083_bib70","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1227\/NEU.0000000000001740","article-title":"Quality of life after endoscopic surgical management of pituitary adenomas","volume":"90","author":"Castle-Kirszbaum","year":"2022","journal-title":"Neurosurgery"},{"issue":"4","key":"10.1016\/j.beem.2026.102083_bib71","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1530\/EJE-19-0344","article-title":"Toward value based health care in pituitary surgery: application of a comprehensive outcome set in perioperative care","volume":"181","author":"Lobatto","year":"2019","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"10.1016\/j.beem.2026.102083_bib72","doi-asserted-by":"crossref","first-page":"567","DOI":"10.3171\/2022.5.JNS2286","article-title":"Quality of life and surgical outcomes in incidental pituitary adenomas undergoing endoscopic endonasal resection","volume":"138","author":"Castle-Kirszbaum","year":"2023","journal-title":"J Neurosurg"},{"key":"10.1016\/j.beem.2026.102083_bib73","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.wneu.2022.05.038","article-title":"Quality of life in craniopharyngioma: a systematic review","volume":"164","author":"Castle-Kirszbaum","year":"2022","journal-title":"World Neurosurg"},{"key":"10.1016\/j.beem.2026.102083_bib74","doi-asserted-by":"crossref","first-page":"e456","DOI":"10.1016\/j.wneu.2023.05.082","article-title":"Headache improvement following endoscopic resection of pituitary adenomas","volume":"176","author":"Delport","year":"2023","journal-title":"World Neurosurg"},{"key":"10.1016\/j.beem.2026.102083_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2023.108079","article-title":"The role of surgical management for prolactin-secreting tumors in the era of dopaminergic agonists: an international multicenter report","volume":"236","author":"Findlay","year":"2024","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.beem.2026.102083_bib76","first-page":"dgaf355","article-title":"Subtle cognitive impairments and psychological complaints in patients with prolactinoma despite biochemical control","author":"van Trigt","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2026.102083_bib77","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.wneu.2015.10.090","article-title":"Cost-effectiveness analysis of microscopic and endoscopic transsphenoidal surgery versus medical therapy in the management of microprolactinoma in the United States","volume":"87","author":"Jethwa","year":"2016","journal-title":"World Neurosurg"},{"issue":"02","key":"10.1016\/j.beem.2026.102083_bib78","first-page":"125","article-title":"Cost-effectiveness analysis of surgical versus medical treatment of prolactinomas","volume":"78","author":"Zygourakis","year":"2017","journal-title":"J Neurol Surg B Skull Base"},{"issue":"9","key":"10.1016\/j.beem.2026.102083_bib79","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/j.clineuro.2013.02.016","article-title":"Transsphenoidal microsurgical results of female patients with prolactinomas","volume":"115","author":"Ikeda","year":"2013","journal-title":"Clin Neurol Neurosurg"},{"issue":"3","key":"10.1016\/j.beem.2026.102083_bib80","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s11102-010-0283-y","article-title":"Pituitary surgery for small prolactinomas as an alternative to treatment with dopamine agonists","volume":"14","author":"Babey","year":"2011","journal-title":"Pituitary"},{"issue":"5","key":"10.1016\/j.beem.2026.102083_bib81","doi-asserted-by":"crossref","first-page":"R205","DOI":"10.1530\/EJE-14-0848","article-title":"Endocrinology in pregnancy: management of the pregnant patient with a prolactinoma","volume":"172","author":"Molitch","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"10.1016\/j.beem.2026.102083_bib82","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1365-2265.2010.03808.x","article-title":"Outcome of 100 pregnancies initiated under treatment with cabergoline in hyperprolactinaemic women","volume":"73","author":"Lebbe","year":"2010","journal-title":"Clin Endocrinol"},{"issue":"5","key":"10.1016\/j.beem.2026.102083_bib83","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1007\/s00701-016-2762-z","article-title":"Reasons and results of endoscopic surgery for prolactinomas: 142 surgical cases","volume":"158","author":"Akin","year":"2016","journal-title":"Acta Neurochir"},{"issue":"1","key":"10.1016\/j.beem.2026.102083_bib84","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s12020-016-1115-2","article-title":"10-year follow-up study comparing primary medical vs. surgical therapy in women with prolactinomas","volume":"55","author":"Andereggen","year":"2017","journal-title":"Endocrine"},{"issue":"3","key":"10.1016\/j.beem.2026.102083_bib85","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s11060-025-04958-6","article-title":"Predictors of favorable long-term outcomes in first-line surgery for microprolactinomas","volume":"172","author":"Andereggen","year":"2025","journal-title":"J Neurooncol"},{"key":"10.1016\/j.beem.2026.102083_bib86","doi-asserted-by":"crossref","first-page":"e349","DOI":"10.1016\/j.wneu.2021.07.035","article-title":"Determinants of surgical remission in prolactinomas: a systematic review and meta-analysis","volume":"154","author":"Wright","year":"2021","journal-title":"World Neurosurg"},{"key":"10.1016\/j.beem.2026.102083_bib87","doi-asserted-by":"crossref","DOI":"10.3389\/fsurg.2024.1283179","article-title":"Prognostic factors for surgical treatment of prolactin-secreting pituitary adenomas","volume":"11","author":"Voznyak","year":"2024","journal-title":"Front Surg"},{"issue":"10","key":"10.1016\/j.beem.2026.102083_bib88","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvab074","article-title":"Cure and hormonal control after prolactinoma resection: case series and systematic review","volume":"5","author":"Penn","year":"2021","journal-title":"J Endocr Soc"},{"issue":"3","key":"10.1016\/j.beem.2026.102083_bib89","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1055\/a-1247-4908","article-title":"Outcomes of transsphenoidal microsurgery for prolactinomas - a contemporary series of 162 cases","volume":"129","author":"Giese","year":"2021","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"6","key":"10.1016\/j.beem.2026.102083_bib90","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1530\/EJE-21-0293","article-title":"Pituitary surgery as alternative to dopamine agonists treatment for microprolactinomas: a cohort study","volume":"185","author":"Baussart","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2026.102083_bib91","doi-asserted-by":"crossref","first-page":"e626","DOI":"10.1016\/j.wneu.2022.10.043","article-title":"Endoscopic endonasal transsphenoidal surgery for patients with prolactinomas: indications and outcomes","volume":"168","author":"Force","year":"2022","journal-title":"World Neurosurg"},{"issue":"13","key":"10.1016\/j.beem.2026.102083_bib92","doi-asserted-by":"crossref","first-page":"3252","DOI":"10.3390\/cancers13133252","article-title":"Reappraising the role of trans-sphenoidal surgery in prolactin-secreting pituitary tumors","volume":"13","author":"Mattogno","year":"2021","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.beem.2026.102083_bib93","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1007\/s00701-024-06198-5","article-title":"Preoperative treatment with dopamine agonist therapy influences surgical outcome in prolactinoma: a retrospective single-center on 159 patients","volume":"166","author":"Ryba","year":"2024","journal-title":"Acta Neurochir"},{"issue":"8","key":"10.1016\/j.beem.2026.102083_bib94","doi-asserted-by":"crossref","DOI":"10.1016\/j.arcmed.2023.102919","article-title":"Efficacy and safety of endoscopic transsphenoidal resection for prolactinoma: a retrospective multicenter case-series","volume":"54","author":"Zandbergen","year":"2023","journal-title":"Arch Med Res"},{"key":"10.1016\/j.beem.2026.102083_bib95","first-page":"1","article-title":"Endoscopic endonasal surgery for prolactin-secreting adenoma: a retrospective multicenter study by the neuroendoscopy section of the Italian Society of Neurosurgery","volume":"1","author":"Zoli","year":"2025","journal-title":"J Neurosurg"},{"issue":"6","key":"10.1016\/j.beem.2026.102083_bib96","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.3171\/2022.8.JNS221890","article-title":"Correlation between tumor volume and serum prolactin and its effect on surgical outcomes in a cohort of 219 prolactinoma patients","volume":"138","author":"Osorio","year":"2023","journal-title":"J Neurosurg"},{"issue":"6","key":"10.1016\/j.beem.2026.102083_bib97","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1007\/s11596-022-2678-1","article-title":"Surgical technique and efficacy analysis of extra-pseudocapsular transnasal transsphenoidal surgery for pituitary microprolactinoma","volume":"42","author":"Wan","year":"2022","journal-title":"Curr Med Sci"},{"issue":"12","key":"10.1016\/j.beem.2026.102083_bib98","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1007\/s40618-021-01569-6","article-title":"First-line surgery in prolactinomas: lessons from a long-term follow-up study in a tertiary referral center","volume":"44","author":"Andereggen","year":"2021","journal-title":"J Endocrinol Invest"},{"issue":"15","key":"10.1016\/j.beem.2026.102083_bib99","doi-asserted-by":"crossref","DOI":"10.3346\/jkms.2021.36.e97","article-title":"Long-term outcome of microscopic transsphenoidal surgery for prolactinomas as an alternative to dopamine agonists","volume":"36","author":"Park","year":"2021","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.beem.2026.102083_bib100","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3389\/fendo.2020.00439","article-title":"Prolactinomas: prognostic factors of early remission after transsphenoidal surgery","volume":"11","author":"Zielinski","year":"2020","journal-title":"Front Endocrinol"},{"issue":"2","key":"10.1016\/j.beem.2026.102083_bib101","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3171\/jns.2002.97.2.0307","article-title":"Predictive value of serum prolactin levels measured immediately after transsphenoidal surgery","volume":"97","author":"Amar","year":"2002","journal-title":"J Neurosurg"},{"issue":"3","key":"10.1016\/j.beem.2026.102083_bib102","doi-asserted-by":"crossref","first-page":"204","DOI":"10.14791\/btrt.2023.0023","article-title":"Role of immediate postoperative prolactin measurement in female prolactinoma patients: predicting long-term remission after complete tumor removal","volume":"11","author":"Lee","year":"2023","journal-title":"Brain Tumor Res Treat"},{"issue":"6","key":"10.1016\/j.beem.2026.102083_bib103","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s11102-021-01168-x","article-title":"Surgery is a safe, effective first-line treatment modality for noninvasive prolactinomas","volume":"24","author":"Park","year":"2021","journal-title":"Pituitary"},{"key":"10.1016\/j.beem.2026.102083_bib104","doi-asserted-by":"crossref","first-page":"636","DOI":"10.3389\/fendo.2018.00636","article-title":"The chance of permanent cure for micro- and macroprolactinomas, medication or surgery? A systematic review and meta-analysis","volume":"9","author":"Ma","year":"2018","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.beem.2026.102083_bib105","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/9930059","article-title":"Surgery and medical treatment in microprolactinoma: a systematic review and meta-analysis","volume":"2021","author":"Lu","year":"2021","journal-title":"Int J Endocrinol"},{"issue":"4","key":"10.1016\/j.beem.2026.102083_bib106","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1093\/neuros\/nyy385","article-title":"Endoscopic transsphenoidal surgery of microprolactinomas: a reappraisal of cure rate based on radiological criteria","volume":"85","author":"Micko","year":"2019","journal-title":"Neurosurg"},{"issue":"7","key":"10.1016\/j.beem.2026.102083_bib107","doi-asserted-by":"crossref","first-page":"3180","DOI":"10.1210\/jcem.87.7.8645","article-title":"Surgical treatment of prolactin-secreting pituitary adenomas: early results and long-term outcome","volume":"87","author":"Losa","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.beem.2026.102083_bib108","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1227\/ons.0000000000000488","article-title":"The HACKD score-predicting extent of resection of pituitary macroadenomas through an endoscopic endonasal transsphenoidal approach","volume":"24","author":"Castle-Kirszbaum","year":"2023","journal-title":"Oper Neurosurg"},{"issue":"1","key":"10.1016\/j.beem.2026.102083_bib109","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3171\/2018.5.JNS18595","article-title":"The medial wall of the cavernous sinus. Part 2: selective medial wall resection in 50 pituitary adenoma patients","volume":"131","author":"Cohen-Cohen","year":"2018","journal-title":"J Neurosurg"},{"issue":"2","key":"10.1016\/j.beem.2026.102083_bib110","doi-asserted-by":"crossref","first-page":"430","DOI":"10.3171\/2017.2.JNS162214","article-title":"Cavernous sinus compartments from the endoscopic endonasal approach: anatomical considerations and surgical relevance to adenoma surgery","volume":"129","author":"Fernandez-Miranda","year":"2018","journal-title":"J Neurosurg"},{"issue":"2","key":"10.1016\/j.beem.2026.102083_bib111","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3171\/2024.4.JNS232662","article-title":"Lateral compartment of the cavernous sinus from the endoscopic endonasal approach: anatomical considerations and surgical relevance to adenoma surgery","volume":"142","author":"Xu","year":"2024","journal-title":"J Neurosurg"},{"issue":"1","key":"10.1016\/j.beem.2026.102083_bib112","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3171\/2018.3.JNS18596","article-title":"The medial wall of the cavernous sinus. Part 1: surgical anatomy, ligaments, and surgical technique for its mobilization and\/or resection","volume":"131","author":"Truong","year":"2019","journal-title":"J Neurosurg"},{"issue":"4","key":"10.1016\/j.beem.2026.102083_bib113","doi-asserted-by":"crossref","first-page":"803","DOI":"10.3171\/2014.12.JNS141083","article-title":"Invasion of the cavernous sinus space in pituitary adenomas: endoscopic verification and its correlation with an MRI-based classification","volume":"122","author":"Micko","year":"2015","journal-title":"J Neurosurg"},{"issue":"4","key":"10.1016\/j.beem.2026.102083_bib114","first-page":"610","article-title":"Pituitary adenomas with invasion of the cavernous sinus space","volume":"33","author":"Knosp","year":"1993","journal-title":"Neurosurgery"},{"issue":"3","key":"10.1016\/j.beem.2026.102083_bib115","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1007\/s11102-022-01221-3","article-title":"The role of endoscopic endonasal surgery in the management of prolactinomas based on their invasiveness into the cavernous sinus","volume":"25","author":"Abou-Al-Shaar","year":"2022","journal-title":"Pituitary"},{"key":"10.1016\/j.beem.2026.102083_bib116","first-page":"1","article-title":"Prolactinomas and Knosp grade: when is surgery the appropriate choice? A systematic review and meta-analysis","volume":"1","author":"Ordo\u00f1ez-Cure","year":"2025","journal-title":"J Neurosurg"},{"issue":"4","key":"10.1016\/j.beem.2026.102083_bib117","doi-asserted-by":"crossref","first-page":"895","DOI":"10.3171\/2025.3.JNS242823","article-title":"Patterns of invasion of the medial wall of the cavernous sinus by pituitary adenomas","volume":"143","author":"Constanzo","year":"2025","journal-title":"J Neurosurg"},{"issue":"1","key":"10.1016\/j.beem.2026.102083_bib118","doi-asserted-by":"crossref","first-page":"9919","DOI":"10.1038\/s41598-022-12980-1","article-title":"Prospective intraoperative and histologic evaluation of cavernous sinus medial wall invasion by pituitary adenomas and its implications for acromegaly remission outcomes","volume":"12","author":"Mohyeldin","year":"2022","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.beem.2026.102083_bib119","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s11102-025-01545-w","article-title":"Endoscopic endonasal transcavernous surgery for a contemporary series of 59 prolactinomas","volume":"28","author":"Nakase","year":"2025","journal-title":"Pituitary"},{"issue":"1","key":"10.1016\/j.beem.2026.102083_bib120","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3171\/2023.12.JNS23922","article-title":"Further investigation of the lateral approach for the resection of Knosp grade 4 pituitary adenomas in endoscopic endonasal surgery","volume":"141","author":"Ding","year":"2024","journal-title":"J Neurosurg"},{"issue":"12","key":"10.1016\/j.beem.2026.102083_bib121","doi-asserted-by":"crossref","first-page":"e1506","DOI":"10.1210\/clinem\/dgad393","article-title":"Long-term follow-up of 84 patients with giant prolactinomas\u2014a Swedish Nationwide Study","volume":"108","author":"Himonakos","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.beem.2026.102083_bib122","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s11102-005-5087-0","article-title":"Combined treatment of invasive giant prolactinomas","volume":"8","author":"Yu","year":"2005","journal-title":"Pituitary"},{"issue":"1","key":"10.1016\/j.beem.2026.102083_bib123","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1530\/EJE-07-0248","article-title":"Operative treatment of prolactinomas: indications and results in a current consecutive series of 212 patients","volume":"158","author":"Kreutzer","year":"2008","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.beem.2026.102083_bib124","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s11102-005-5086-1","article-title":"Surgical outcomes in hyporesponsive prolactinomas: analysis of patients with resistance or intolerance to dopamine agonists","volume":"8","author":"Hamilton","year":"2005","journal-title":"Pituitary"},{"issue":"6","key":"10.1016\/j.beem.2026.102083_bib125","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1007\/s11102-021-01188-7","article-title":"Surgical outcomes of medically failed prolactinomas: a systematic review and meta-analysis","volume":"24","author":"Yagnik","year":"2021","journal-title":"Pituitary"},{"issue":"3","key":"10.1016\/j.beem.2026.102083_bib126","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1007\/s11102-022-01221-3","article-title":"The role of endoscopic endonasal surgery in the management of prolactinomas based on their invasiveness into the cavernous sinus","volume":"25","author":"Abou-Al-Shaar","year":"2022","journal-title":"Pituitary"},{"issue":"3","key":"10.1016\/j.beem.2026.102083_bib127","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s11102-008-0135-1","article-title":"Pre-operative dopamine agonist therapy improves post-operative tumor control following prolactinoma resection","volume":"12","author":"Sughrue","year":"2009","journal-title":"Pituitary"},{"issue":"7","key":"10.1016\/j.beem.2026.102083_bib128","doi-asserted-by":"crossref","first-page":"3180","DOI":"10.1210\/jcem.87.7.8645","article-title":"Surgical treatment of prolactin-secreting pituitary adenomas: early results and long-term outcome","volume":"87","author":"Losa","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.beem.2026.102083_bib129","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s11102-010-0261-4","article-title":"Effect of dopaminergic drug treatment on surgical findings in prolactinomas","volume":"14","author":"Menucci","year":"2011","journal-title":"Pituitary"},{"issue":"1","key":"10.1016\/j.beem.2026.102083_bib130","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/mds.22385","article-title":"Cardiac and noncardiac fibrotic reactions caused by ergot-and nonergot-derived dopamine agonists","volume":"24","author":"Andersohn","year":"2009","journal-title":"Mov Disord"},{"issue":"1","key":"10.1016\/j.beem.2026.102083_bib131","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1056\/NEJMp068265","article-title":"Drugs and valvular heart disease","volume":"356","author":"Roth","year":"2007","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.beem.2026.102083_bib132","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1210\/clinem\/dgad758","article-title":"Presurgical medical treatment in prolactinomas: surgical implications and pathological characteristics from 290 cases","volume":"109","author":"Chen","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.beem.2026.102083_bib133","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3349\/ymj.2022.0406","article-title":"Surgical treatment of prolactinomas: potential role as a first-line treatment modality","volume":"64","author":"Kim","year":"2023","journal-title":"Yonsei Med J"},{"issue":"1","key":"10.1016\/j.beem.2026.102083_bib134","first-page":"653","article-title":"The PRolaCT studies - a study protocol for a combined randomised clinical trial and observational cohort study design in prolactinoma","volume":"22","author":"Zandbergen","year":"2021","journal-title":"Dutch Prolactino Study Group Ed Trials"},{"issue":"6","key":"10.1016\/j.beem.2026.102083_bib135","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.3171\/2024.8.JNS232715","article-title":"Association between pituitary adenoma consistency, resection techniques, and patient outcomes: a single-institution experience","volume":"142","author":"Guerra","year":"2025","journal-title":"J Neurosurg"},{"issue":"1","key":"10.1016\/j.beem.2026.102083_bib136","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12902-023-01334-1","article-title":"Pituitary adenoma consistency affects postoperative hormone function: a retrospective study","volume":"23","author":"De Alcubierre","year":"2023","journal-title":"BMC Endocr Disord"},{"issue":"5","key":"10.1016\/j.beem.2026.102083_bib137","doi-asserted-by":"crossref","DOI":"10.1038\/s41574-024-00953-5","article-title":"The shift of therapeutic strategy for prolactinomas: surgery as the first-line option","volume":"20","author":"Wu","year":"2024","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.beem.2026.102083_bib138","first-page":"1","article-title":"Association between facility volume with treatment patterns and short-term surgical outcomes in pituitary adenoma: a National Cancer Database analysis","volume":"1","author":"Pham","year":"2025","journal-title":"J Neurosurg"},{"issue":"4","key":"10.1016\/j.beem.2026.102083_bib139","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.3171\/2024.6.JNS232336","article-title":"Development and validation of a predictive scoring model for complications following endoscopic endonasal skull base surgery","volume":"142","author":"Vignolles-Jeong","year":"2024","journal-title":"J Neurosurg"},{"issue":"2","key":"10.1016\/j.beem.2026.102083_bib140","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11102-025-01507-2","article-title":"Frailty and pituitary surgery: a systematic review","volume":"28","author":"Castle-Kirszbaum","year":"2025","journal-title":"Pituitary"},{"issue":"8","key":"10.1016\/j.beem.2026.102083_bib141","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1136\/jnnp-2012-303194","article-title":"Short-term outcome of endoscopic versus microscopic pituitary adenoma surgery: a systematic review and meta-analysis","volume":"84","author":"Ammirati","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"10.1016\/j.beem.2026.102083_bib142","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.3171\/2018.11.JNS181238","article-title":"Results of a prospective multicenter controlled study comparing surgical outcomes of microscopic versus fully endoscopic transsphenoidal surgery for nonfunctioning pituitary adenomas: the Transsphenoidal Extent of Resection (TRANSSPHER) Study","volume":"132","author":"Little","year":"2019","journal-title":"J Neurosurg"},{"issue":"6","key":"10.1016\/j.beem.2026.102083_bib143","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s11102-021-01159-y","article-title":"Diabetes insipidus after endoscopic transsphenoidal surgery: multicenter experience and development of the SALT score","volume":"24","author":"Castle-Kirszbaum","year":"2021","journal-title":"Pituitary"},{"issue":"5","key":"10.1016\/j.beem.2026.102083_bib144","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1007\/s10143-020-01450-9","article-title":"Hyponatraemia and hypernatraemia: disorders of water balance in neurosurgery","volume":"44","author":"Castle-Kirszbaum","year":"2021","journal-title":"Neurosurg Rev"},{"issue":"1","key":"10.1016\/j.beem.2026.102083_bib145","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s10143-021-01617-y","article-title":"Predictors of visual and endocrine outcomes after endoscopic transsphenoidal surgery for pituitary adenomas","volume":"45","author":"Castle-Kirszbaum","year":"2022","journal-title":"Neurosurg Rev"},{"issue":"5","key":"10.1016\/j.beem.2026.102083_bib146","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1093\/neuros\/nyaa148","article-title":"Diabetes insipidus after endoscopic transsphenoidal surgery","volume":"87","author":"Burke","year":"2020","journal-title":"Neurosurgery"},{"issue":"5","key":"10.1016\/j.beem.2026.102083_bib147","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s11102-023-01337-0","article-title":"Giant prolactinomas, a detailed analysis of 196 adult cases","volume":"26","author":"Billion","year":"2023","journal-title":"Pituitary"},{"issue":"4","key":"10.1016\/j.beem.2026.102083_bib148","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/s11102-023-01332-5","article-title":"Efficacy and safety of cavernous sinus medial wall resection in pituitary adenoma surgery: a systematic review and a single-arm meta-analysis","volume":"26","author":"Pontes","year":"2023","journal-title":"Pituitary"},{"issue":"5","key":"10.1016\/j.beem.2026.102083_bib149","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s11102-023-01345-0","article-title":"Pilot study to define criteria for Pituitary Tumors Centers of Excellence (PTCOE): results of an audit of leading international centers","volume":"26","author":"Giustina","year":"2023","journal-title":"Pituitary"},{"issue":"3","key":"10.1016\/j.beem.2026.102083_bib150","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1007\/s11102-022-01221-3","article-title":"The role of endoscopic endonasal surgery in the management of prolactinomas based on their invasiveness into the cavernous sinus","volume":"25","author":"Abou-Al-Shaar","year":"2022","journal-title":"Pituitary"},{"issue":"5","key":"10.1016\/j.beem.2026.102083_bib151","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s11102-018-0904-4","article-title":"The experience with transsphenoidal surgery and its importance to outcomes","volume":"21","author":"Honegger","year":"2018","journal-title":"Pituitary"},{"issue":"1","key":"10.1016\/j.beem.2026.102083_bib152","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s11102-025-01497-1","article-title":"Outcomes in surgical management of microprolactinomas: an international multi-institutional series","volume":"28","author":"Golub","year":"2025","journal-title":"Pituitary"},{"key":"10.1016\/j.beem.2026.102083_bib153","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2023.108079","article-title":"The role of surgical management for prolactin-secreting tumors in the era of dopaminergic agonists: an international multicenter report","volume":"236","author":"Findlay","year":"2024","journal-title":"Clin Neurol Neurosurg"},{"issue":"2","key":"10.1016\/j.beem.2026.102083_bib154","doi-asserted-by":"crossref","first-page":"e711","DOI":"10.1210\/clinem\/dgad541","article-title":"A prospective, multicenter, observational study of surgical vs nonsurgical management for pituitary apoplexy","volume":"109","author":"Mamelak","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.beem.2026.102083_bib155","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1210\/jc.2013-1249","article-title":"The prevalence and natural history of pituitary hemorrhage in prolactinoma","volume":"98","author":"Sarwar","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.beem.2026.102083_bib156","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/cen.15120","article-title":"Visual morbidity in macroprolactinoma: a retrospective cohort study","volume":"101","author":"Rudman","year":"2024","journal-title":"Clin Endocrinol"},{"issue":"3","key":"10.1016\/j.beem.2026.102083_bib157","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s42000-021-00307-0","article-title":"Comparison of the effects of medical and surgical treatments in giant prolactinoma: a single-center experience","volume":"20","author":"Cander","year":"2021","journal-title":"Horm (Athens)"},{"key":"10.1016\/j.beem.2026.102083_bib158","article-title":"Comprehensive comparison of visual outcomes in macro and giant prolactinoma cohorts managed with medical versus surgical treatment","author":"Maldonado","year":"2025","journal-title":"Neurosurgery"},{"issue":"6","key":"10.1016\/j.beem.2026.102083_bib159","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1007\/s00701-020-04300-1","article-title":"Transsphenoidal resection for pituitary adenoma in elderly versus younger patients: a systematic review and meta-analysis","volume":"162","author":"Tuleasca","year":"2020","journal-title":"Acta Neurochir (Wien)"},{"issue":"6","key":"10.1016\/j.beem.2026.102083_bib160","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1007\/s11102-021-01166-z","article-title":"Frailty does not preclude surgical success after endoscopic transsphenoidal surgery for pituitary adenomas","volume":"24","author":"Castle-Kirszbaum","year":"2021","journal-title":"Pituitary"},{"issue":"9","key":"10.1016\/j.beem.2026.102083_bib161","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1111\/jgs.13590","article-title":"Comparison of pituitary adenomas in elderly and younger adults: clinical characteristics, surgical outcomes, and prognosis","volume":"63","author":"Liu","year":"2015","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"10.1016\/j.beem.2026.102083_bib162","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s12672-019-00363-4","article-title":"Cabergoline withdrawal before and after menopause: outcomes in microprolactinomas","volume":"10","author":"Indirli","year":"2019","journal-title":"Horm Canc"},{"issue":"5","key":"10.1016\/j.beem.2026.102083_bib163","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/cen.13399","article-title":"Prolactinomas diagnosed in the postmenopausal period: Clinical phenotype and outcomes","volume":"87","author":"Santharam","year":"2017","journal-title":"Clin Endocrinol"},{"issue":"1","key":"10.1016\/j.beem.2026.102083_bib164","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s12020-017-1438-7","article-title":"Prolactinoma through the female life cycle","volume":"59","author":"Cocks Eschler","year":"2018","journal-title":"Endocrine"},{"issue":"1","key":"10.1016\/j.beem.2026.102083_bib165","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1210\/jc.2012-3039","article-title":"Results of a single-center observational 10-year survey study on recurrence of hyperprolactinemia after pregnancy and lactation","volume":"98","author":"Auriemma","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.beem.2026.102083_bib166","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s10143-022-01909-x","article-title":"Methods of preoperative prediction of pituitary adenoma consistency: a systematic review","volume":"46","author":"\u010cern\u00fd","year":"2022","journal-title":"Neurosurg Rev"},{"issue":"6","key":"10.1016\/j.beem.2026.102083_bib167","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.3171\/2022.3.JNS212940","article-title":"Pituitary adenoma in the elderly: surgical outcomes and treatment trends in the United States","volume":"137","author":"Chalif","year":"2022","journal-title":"J Neurosurg"},{"issue":"5","key":"10.1016\/j.beem.2026.102083_bib168","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/alr.22916","article-title":"The association of frailty, age, and ASA classification with postoperative outcomes in minimally invasive pituitary surgery","volume":"12","author":"Martin","year":"2022","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.beem.2026.102083_bib169","first-page":"22","article-title":"Impact of modified Frailty Index-11 (mFI-11) on postoperative complications in patients undergoing transsphenoidal resection of pituitary tumors: analysis of 2006-2014 ACS-NSQIP database","volume":"92","author":"Nguyen","year":"2021","journal-title":"J Clin Neurosci Off Jo Neurosurg Soc Austr"},{"issue":"101528275","key":"10.1016\/j.beem.2026.102083_bib170","doi-asserted-by":"crossref","first-page":"e347","DOI":"10.1016\/j.wneu.2022.02.002","article-title":"Worse pituitary adenoma surgical outcomes predicted by increasing frailty, not age","volume":"161","author":"Thommen","year":"2022","journal-title":"World Neurosurg"},{"issue":"2","key":"10.1016\/j.beem.2026.102083_bib171","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3171\/2018.8.JNS181875","article-title":"Impact of frailty on short-term outcomes in patients undergoing transsphenoidal pituitary surgery","volume":"132","author":"Asemota","year":"2020","journal-title":"J Neurosurg"},{"key":"10.1016\/j.beem.2026.102083_bib172","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.wneu.2015.10.090","article-title":"Cost-effectiveness analysis of microscopic and endoscopic transsphenoidal surgery versus medical therapy in the management of microprolactinoma in the United States","volume":"87","author":"Jethwa","year":"2016","journal-title":"World Neurosurg"},{"issue":"4","key":"10.1016\/j.beem.2026.102083_bib173","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1097\/SCS.0000000000003456","article-title":"An economic analysis of bromocriptine versus trans-sphenoidal surgery for the treatment of Prolactinoma","volume":"28","author":"Duan","year":"2017","journal-title":"J Craniofac Surg"},{"issue":"3","key":"10.1016\/j.beem.2026.102083_bib174","doi-asserted-by":"crossref","first-page":"712","DOI":"10.3171\/2023.6.JNS23570","article-title":"Socioeconomic differences between medically and surgically treated prolactinomas: a retrospective review of 598 patients","volume":"140","author":"Osorio","year":"2023","journal-title":"J Neurosurg"},{"issue":"6","key":"10.1016\/j.beem.2026.102083_bib175","doi-asserted-by":"crossref","first-page":"807","DOI":"10.3171\/jns.1987.67.6.0807","article-title":"Short-term preoperative treatment of macroprolactinomas by dopamine agonists","volume":"67","author":"Fahlbusch","year":"1987","journal-title":"J Neurosurg"}],"container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X26000047?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X26000047?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T11:20:11Z","timestamp":1788866411000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X26000047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":175,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S1521690X26000047"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2026.102083","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Surgery for prolactinoma","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2026.102083","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102083"}}